NeoGenomics Inc (NEO)

Industry Diagnostics & Research

This stock can be held in an Investment ISA and an Investment Account
Sell

$7.21

Buy

$7.28

arrow-up$0.865 (+13.53%)

NeoGenomics Inc operates a network of cancer-related testing laboratories in Ft. Myers and Tampa, Florida, Irvine, California and Nashville, and Tennessee.
Prices updated at 02 May 2025, 00:39 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
Ms. Lynn A. Tetrault, J.D.
CEO
Mr. Anthony P. Zook
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
2,200
Head office
9490 NeoGenomics Way
Fort Myers
United States
33912
mobile
+1 239 768-0600
letter
bill.bonello@neogenomics.com

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Anthony P. Zook
Director and Chief Executive Officer
0.08m--0.32m-
Mr. Warren Stone
President and Chief Operating Officer
0.56m--3.18m-
Ms. Beth Eastland
Senior Vice President, Enterprise Sales
-----
Mr. Jeffrey S. Sherman
Chief Financial Officer
0.54m--3.48m-
Ms. Lynn A. Tetrault, J.D.
Chairman of the Board
0.13m--0.37m-
Mr. Michael A. Kelly
Independent Director
0.08m--0.32m-
Dr. Alison L. Hannah, M.D.
Independent Director
0.07m--0.31m-
Mr. Gregory D. Aunan
Chief Accounting Officer and Senior Vice President
-----
Mr. Stephen M. Kanovsky
Independent Director
0.07m--0.31m-
Mr. David B. Perez
Independent Director
0.07m--0.31m-
Ms. Alicia C. Olivo
Executive Vice President, Business Development, General Counsel and Corporate Secretary
0.51m--2.24m-
Ms. Elizabeth A. Floegel
Independent Director
0.07m--0.31m-
Dr. Neil Gunn
Independent Director
0.07m--0.31m-
Ms. Felicia Williams
Independent Director
-----
Ms. Cynthia J. Dieter
Chief Accounting Officer and Controller
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
BlackRock Inc20,243,6670.006753323241.66901930 Apr 202515.73
Vanguard Group Inc14,239,8870.004091957931.39413130 Apr 202511.06
BlackRock Fund Advisors13,878,2650.97983-32800-30 Apr 202510.78
iShares Core S&P Small-Cap ETF7,809,7040.1052138460.04927130 Apr 20256.07
T. Rowe Price Investment Management,Inc.6,528,1110.06637-13289-0.20315230 Apr 20255.07

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
07 Dec 2024-Mr. Jeffrey S. Sherman--123,754--
01 Dec 2024-Mr. Warren Stone--84,822--
15 Nov 2024-Ms. Alicia C. Olivo15.3679,47537,129--
01 Sep 2024-Ms. Alicia C. Olivo--42,147--
15 Aug 2024-Ms. Alicia C. Olivo16.0516,69543,813--
10 Aug 2024-Ms. Lynn A. Tetrault, J.D.-----
10 Aug 2024-Ms. Lynn A. Tetrault, J.D.--61,398--
10 Aug 2024-Mr. Anthony P. Zook-----
10 Aug 2024-Mr. Anthony P. Zook--11,336--
10 Aug 2024-Mr. Michael A. Kelly-----
10 Aug 2024-Mr. Michael A. Kelly--31,755--
10 Aug 2024-Dr. Alison L. Hannah, M.D.--118,769--
10 Aug 2024-Dr. Alison L. Hannah, M.D.-----
10 Aug 2024-Mr. Stephen M. Kanovsky-----
10 Aug 2024-Mr. Stephen M. Kanovsky--36,090--
10 Aug 2024-Mr. David B. Perez-----
10 Aug 2024-Mr. David B. Perez--21,636--
10 Aug 2024-Ms. Elizabeth A. Floegel--11,336--
10 Aug 2024-Ms. Elizabeth A. Floegel-----
10 Aug 2024-Dr. Neil Gunn-----
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.